Gaining insight into irrational off‐label use of vidarabine through analysis of a spontaneous reporting system in China

Author:

Li Haona12ORCID,Deng Jianxiong3,Yu Peiming4,Deng Lewen3,Ren Xuequn12

Affiliation:

1. Huaihe Hospital of Henan University Kaifeng China

2. Institutes of Evidence‐Based Medicine and Knowledge Translation Henan University Kaifeng China

3. Adverse Drug Reaction Monitoring Centre of Guangdong Province Guangzhou China

4. School of Pharmacy Henan University Kaifeng China

Funder

Henan Provincial Project of Science and Technology

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Overuse of medications in low- and middle-income countries: a scoping review;Bulletin of the World Health Organization;2023-01-01

2. Industrially Relevant Enzyme Cascades for Drug Synthesis and Their Ecological Assessment;International Journal of Molecular Sciences;2022-03-25

3. Drug-Related Deaths in China: An Analysis of a Spontaneous Reporting System;Frontiers in Pharmacology;2022-02-25

4. Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems;Therapeutics and Clinical Risk Management;2021-08

5. Vidarabine;Reactions Weekly;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3